- Report
- September 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- August 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2021
- 420 Pages
United States
From €2184EUR$2,400USD£1,873GBP
- Report
- March 2024
- 397 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- April 2024
- 160 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- March 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- October 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,458GBP
- Report
- October 2022
- 113 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- March 2018
- 20 Pages
Global
From €9101EUR$10,000USD£7,802GBP
- Report
- January 2025
- 91 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 135 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- July 2022
- 220 Pages
Global
From €3249EUR$3,570USD£2,785GBP

Paliperidone is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is an atypical antipsychotic drug, meaning it works differently than traditional antipsychotics. Paliperidone works by blocking certain receptors in the brain, which helps to reduce symptoms of mental illness. It is available in both oral and injectable forms.
Paliperidone is a relatively new drug, having been approved by the FDA in 2006. It is generally well-tolerated and has fewer side effects than other antipsychotics. It is also effective in treating both positive and negative symptoms of mental illness.
The Paliperidone market is highly competitive, with many companies offering the drug. Some of the major players in the market include Johnson & Johnson, Novartis, Teva Pharmaceuticals, and Mylan. Other companies such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Intas Pharmaceuticals also offer Paliperidone. Show Less Read more